Radiation Therapy for Primary Sigmoid Colon Adenocarcinoma
Radiation therapy is NOT routinely indicated for primary sigmoid colon adenocarcinoma, as surgery followed by systemic chemotherapy (for high-risk disease) remains the standard of care. 1, 2
Standard Treatment Approach
The current standard for localized sigmoid colon cancer is surgical resection (complete mesocolic excision with adequate lymph node sampling of at least 12 nodes) followed by adjuvant chemotherapy for stage III and high-risk stage II disease. 2 Radiation therapy is reserved only for specific high-risk situations that are uncommon in sigmoid colon cancer. 2
Limited Indications for Radiation in Sigmoid Colon Cancer
Radiation therapy may be considered in the following specific circumstances:
T4b Locally Invasive Disease
- For T4b sigmoid colon tumors with local invasion to adjacent structures, local radiotherapy can improve treatment response rates and increase the probability of conversion to resectable disease. 1
- This represents the primary indication where radiation has demonstrated benefit for sigmoid colon cancer. 1
Postoperative High-Risk Features
Radiation therapy (45-50.4 Gy in 1.8-2.0 Gy fractions with concurrent 5-FU-based chemotherapy) should be considered for: 2
- Positive or close surgical margins 2
- Tumor perforation in the tumor area 2
- Defects in the mesorectum 3
- High risk of local recurrence if preoperative radiotherapy was not given 3
Technical Specifications When Radiation Is Used
- Radiation fields should include the tumor bed as defined by preoperative imaging and/or surgical clips 2
- Typical dose: 45-50.4 Gy in 1.8-2.0 Gy fractions 2
- Conformal beam radiation should be routinely used; IMRT reserved for unique situations including re-irradiation 2
- Administered postoperatively with concurrent 5-FU-based chemotherapy 2
Key Distinction: Sigmoid vs. Rectal Cancer
This is a critical pitfall to avoid: Sigmoid colon cancer is treated fundamentally differently from rectal cancer. While preoperative or postoperative chemoradiotherapy is standard for locally advanced rectal cancer (T3-T4 or N+), 3, 4 this does NOT apply to sigmoid colon cancer, which is located above the peritoneal reflection. 1 The sigmoid colon has different patterns of spread, lower rates of local recurrence after adequate surgery, and responds better to systemic chemotherapy alone. 5
Metastatic or Unresectable Disease
For patients with unresectable sigmoid colon cancer:
- Conversion chemotherapy (fluoropyrimidine-based, with oxaliplatin or irinotecan, ± targeted therapy) is the primary approach. 1
- For MSI-H/dMMR tumors, PD-1 immune checkpoint inhibitors should be considered for conversion therapy or palliative treatment. 1
- Concurrent chemoradiotherapy is listed as a Grade II (alternative) option only for specific locally invasive cases. 1
Historical Context
Older retrospective data from the 1980s suggested potential benefit from postoperative pelvic radiation for B2,3 sigmoid cancers (improved 5-year survival 100% vs 64%, P<0.05), 6 but modern guidelines have moved away from routine radiation for colon cancer based on improved surgical techniques, better systemic therapies, and recognition of different biology compared to rectal cancer. 2